Just for clarity here, you were saying similar things all the way down from 30 cents:
Why is this time different?
Its the biotech space, hardly low risk imo. IMU will be needing cash first half of next year, if they cant get a re-rating before then, its going to have to be at a discount to what it is now. So really its a hail mary on the announcements made in the next 5 months or so.
Im genuinely curious why you think its low risk?
IMU Price at posting:
3.6¢ Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)